GILOTRIF

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jul 12, 2013

   13 yr 2 mo ago

2. Patent RE43431 expires

   Listed drug substance patent expiration.

   Jan 13, 2026

   5 mo ago

3. Today

4. Patent RE43431*PED expires

   Listed listed patent expiration.

   Jul 13, 2026

   in 24 d

5. Patent 9539258 expires

   Listed method-of-use patent (U-1950) expiration.

   Nov 09, 2026

   in 5 mo

6. Patent 9539258*PED expires

   Listed listed patent expiration.

   May 09, 2027

   in 11 mo

7. Patent 8426586 expires

   Listed drug substance patent expiration.

   Oct 10, 2029

   in 3 yr 4 mo

8. Patent 8545884 expires

   Listed drug product patent expiration.

   Dec 19, 2029

   in 3 yr 7 mo

9. Patent 8426586*PED expires

   Listed listed patent expiration.

   Apr 10, 2030

   in 3 yr 10 mo

10. Patent 8545884*PED expires

    Listed listed patent expiration.

    Jun 19, 2030

    in 4 yr 1 mo

11. Patent 10004743 expires

    Listed drug product patent expiration.

    Jul 05, 2030

    in 4 yr 1 mo

12. Patent 10004743*PED expires

    Listed listed patent expiration.

    Jan 05, 2031

    in 4 yr 7 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)